InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Jain Rita, Director. Officer active across 2 companies, notably ChemoCentryx, Inc.. In total, 6 reports have been logged. Activity tracked since 21 May 2021. The latest transaction was disclosed on 15 June 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Rita Jain is a board member and Executive Vice President, Chief Medical Officer at ChemoCentryx, Inc. She brings her medical expertise to guide the strategic and operational decisions of the company.